Anthelmintic Drugs Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : March 2021 Pages : 155 Category: Pharma & Healthcare Report Code : HC0316242
Anthelmintic Drugs Market by Type(Oral Drugs, Injectable) Application (For Human, For Animal) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
Anthelmintic Drugs Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Anthelmintics or antihelminthics are a group of antiparasitic drugs that by either stunning or killing them and without causing any harm to the host, remove parasitic worms and other internal parasites from the body.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users).
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novartis
- Mankind Pharma
- Pfizer
- Merck
- Cipla
- Bayer
- Sun Pharmaceutical Industries
- Johnson & Johnson
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Anthelmintic DrugsMarket Classification
· Anthelmintic Drugs Market, ByType, Estimates and Forecast, 2017-2027 ($Million)
o Oral Drugs
o Injectable
· Anthelmintic Drugs Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o For Human
o For Animal
· Anthelmintic Drugs Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Novartis
o Mankind Pharma
o Pfizer
o Merck
o Cipla
o Bayer
o Sun Pharmaceutical Industries
o Johnson & Johnson
· Anthelmintic Drugs Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Anthelmintic Drugs Market, By Country
o U.S. Anthelmintic Drugs Market
o Canada Anthelmintic Drugs Market
o Mexico Anthelmintic Drugs Market
o Europe
§ Europe Anthelmintic Drugs Market, By Country
· Germany Anthelmintic Drugs Market
o UK Anthelmintic Drugs Market
o France Anthelmintic Drugs Market
o RussiaAnthelmintic Drugs Market
o Italy Anthelmintic Drugs Market
o Rest of Europe Anthelmintic Drugs Market
o Asia-Pacific
§ Asia-Pacific Anthelmintic Drugs Market, By Country
o ChinaAnthelmintic Drugs Market
o Japan Anthelmintic Drugs Market
o South KoreaAnthelmintic Drugs Market
o India Anthelmintic Drugs Market
o Southeast AsiaAnthelmintic Drugs Market
o Rest of Asia-Pacific Anthelmintic Drugs Market
o South America
§ South AmericaAnthelmintic Drugs Market
o Brazil Anthelmintic Drugs Market
o ArgentinaAnthelmintic Drugs Market
o ColumbiaAnthelmintic Drugs Market
o Rest of South America Anthelmintic Drugs Market
o Middle East and Africa
§ Middle East and AfricaAnthelmintic Drugs Market
o Saudi ArabiaAnthelmintic Drugs Market
o UAEAnthelmintic Drugs Market
o EgyptAnthelmintic Drugs Market
o NigeriaAnthelmintic Drugs Market
o South Africa Anthelmintic Drugs Market
o Rest of MEA Anthelmintic Drugs Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Anthelmintic Drugs Market, By Type
5.1. Introduction
5.2. Global Anthelmintic Drugs Revenue and Market Share by Type (2017-2021)
5.2.1. Global Anthelmintic Drugs Revenue and Revenue Share by Type (2017-2021)
5.3. Oral Drugs
5.3.1. Global Oral Drugs Revenue and Growth Rate (2017-2021)
5.4. Injectable
5.4.1. Global Injectable Revenue and Growth Rate (2017-2021)
6. Anthelmintic Drugs Market, By Application
6.1. Introduction
6.2. Global Anthelmintic Drugs Revenue and Market Share by Application (2017-2021)
6.2.1. Global Anthelmintic Drugs Revenue and Revenue Share by Application (2017-2021)
6.3. For Human
6.3.1. Global For Human Revenue and Growth Rate (2017-2021)
6.4. For Animal
6.4.1. Global For Animal Revenue and Growth Rate (2017-2021)
7. Anthelmintic Drugs Market, By Region
7.1. Introduction
7.2. Global Anthelmintic Drugs Revenue and Market Share by Regions
7.2.1. Global Anthelmintic Drugs Revenue by Regions (2017-2021)
7.3. North America Anthelmintic Drugs by Countries
7.3.1. North America Anthelmintic Drugs Revenue and Growth Rate (2017-2021)
7.3.2. North America Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Anthelmintic Drugs by Countries
7.4.1. Europe Anthelmintic Drugs Revenue and Growth Rate (2017-2021)
7.4.2. Europe Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Anthelmintic Drugs by Countries
7.5.1. Asia-Pacific Anthelmintic Drugs Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Anthelmintic Drugs by Countries
7.6.1. South America Anthelmintic Drugs Revenue and Growth Rate (2017-2021)
7.6.2. South America Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Anthelmintic Drugs by Countries
7.7.1. Middle East and Africa Anthelmintic Drugs Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Novartis
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Mankind Pharma
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Pfizer
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Merck
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Cipla
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bayer
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Sun Pharmaceutical Industries
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Johnson & Johnson
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
9. Anthelmintic Drugs Market Forecast (2022-2027)
9.1. Global Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Anthelmintic Drugs Market Forecast by Regions (2022-2027)
9.2.1. North America Anthelmintic Drugs Market Forecast (2022-2027)
9.2.1.1. United States Anthelmintic Drugs Market Forecast (2022-2027)
9.2.1.2. Canada Anthelmintic Drugs Market Forecast (2022-2027)
9.2.1.3. Mexico Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2. Europe Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.1. Germany Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.2. France Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.3. UK Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.4. Russia Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.5. Italy Anthelmintic Drugs Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3. Asia-Pacific Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.1. China Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.2. Japan Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.3. Korea Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.4. India Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Anthelmintic Drugs Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Anthelmintic Drugs Market Forecast (2022-2027)
9.2.4. South America Anthelmintic Drugs Market Forecast (2022-2027)
9.2.4.1. Brazil Anthelmintic Drugs Market Forecast (2022-2027)
9.2.4.2. Argentina Anthelmintic Drugs Market Forecast (2022-2027)
9.2.4.3. Columbia Anthelmintic Drugs Market Forecast (2022-2027)
9.2.4.4. Rest of South America Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5. Middle East and Africa Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.3. Egypt Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.4. Nigeria Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.5. South Africa Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.6. Turkey Anthelmintic Drugs Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Anthelmintic Drugs Market Forecast (2022-2027)
9.3. Anthelmintic Drugs Market Forecast by Type (2022-2027)
9.3.1. Anthelmintic Drugs Forecast by Type (2022-2027)
9.3.2. Anthelmintic Drugs Market Share Forecast by Type (2022-2027)
9.4. Anthelmintic Drugs Market Forecast by Application (2022-2027)
9.4.1. Anthelmintic Drugs Forecast by Application (2022-2027)
9.4.2. Anthelmintic Drugs Market Share Forecast by Application (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Anthelmintic Drugs Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Anthelmintic Drugs Revenue and Revenue Share by Type (2017-2019)
Figure Global Oral Drugs Revenue and Growth Rate (2017-2019)
Figure Global Injectable Revenue and Growth Rate (2017-2019)
Table Global Anthelmintic Drugs Revenue and Revenue Share by Application (2017-2019)
Figure Global For Human Revenue and Growth Rate (2017-2019)
Figure Global For Animal Revenue and Growth Rate (2017-2019)
Table Global Anthelmintic Drugs Revenue by Regions (2017-2019)
Figure North America Anthelmintic Drugs Growth Rate (2017-2019)
Figure North America Anthelmintic Drugs Revenue and Growth Rate (2017-2019)
Figure North America Anthelmintic Drugs by Countries (2017-2019)
Figure North America Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure United States Anthelmintic Drugs Growth Rate (2017-2019)
Figure United States Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Anthelmintic Drugs Growth Rate (2017-2019)
Figure Canada Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Anthelmintic Drugs Growth Rate (2017-2019)
Figure Mexico Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Anthelmintic Drugs Growth Rate (2017-2019)
Figure Europe Anthelmintic Drugs Revenue and Growth Rate (2017-2019)
Figure Europe Anthelmintic Drugs by Countries (2017-2019)
Figure Europe Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Germany Anthelmintic Drugs Growth Rate (2017-2019)
Figure Germany Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Anthelmintic Drugs Growth Rate (2017-2019)
Figure France Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Anthelmintic Drugs Growth Rate (2017-2019)
Figure UK Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Anthelmintic Drugs Growth Rate (2017-2019)
Figure Russia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Anthelmintic Drugs Growth Rate (2017-2019)
Figure Italy Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Anthelmintic Drugs Growth Rate (2017-2019)
Figure Rest of Europe Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Anthelmintic Drugs Growth Rate (2017-2019)
Figure Asia-Pacific Anthelmintic Drugs Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Anthelmintic Drugs by Countries (2017-2019)
Figure Asia-Pacific Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure China Anthelmintic Drugs Growth Rate (2017-2019)
Figure China Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Anthelmintic Drugs Growth Rate (2017-2019)
Figure Japan Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Anthelmintic Drugs Growth Rate (2017-2019)
Figure Korea Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Anthelmintic Drugs Growth Rate (2017-2019)
Figure India Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Anthelmintic Drugs Growth Rate (2017-2019)
Figure Southeast Asia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Anthelmintic Drugs Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Anthelmintic Drugs Growth Rate (2017-2019)
Figure South America Anthelmintic Drugs Revenue and Growth Rate (2017-2019)
Figure South America Anthelmintic Drugs by Countries (2017-2019)
Figure South America Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Anthelmintic Drugs Growth Rate (2017-2019)
Figure Brazil Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Anthelmintic Drugs Growth Rate (2017-2019)
Figure Argentina Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Anthelmintic Drugs Growth Rate (2017-2019)
Figure Columbia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Anthelmintic Drugs Growth Rate (2017-2019)
Figure Rest of South America Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Anthelmintic Drugs Growth Rate (2017-2019)
Figure Middle East and Africa Anthelmintic Drugs Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Anthelmintic Drugs by Countries (2017-2019)
Figure Middle East and Africa Anthelmintic Drugs Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Anthelmintic Drugs Growth Rate (2017-2019)
Figure Saudi Arabia Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Anthelmintic Drugs Growth Rate (2017-2019)
Figure United Arab Emirates Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Anthelmintic Drugs Growth Rate (2017-2019)
Figure Egypt Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Anthelmintic Drugs Growth Rate (2017-2019)
Figure Nigeria Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Anthelmintic Drugs Growth Rate (2017-2019)
Figure South Africa Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Anthelmintic Drugs Growth Rate (2017-2019)
Figure Turkey Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Anthelmintic Drugs Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2017-2019)
Table Novartis Anthelmintic Drugs Financial Overview
Table Mankind Pharma Anthelmintic Drugs Financial Overview
Table Pfizer Anthelmintic Drugs Financial Overview
Table Merck Anthelmintic Drugs Financial Overview
Table Cipla Anthelmintic Drugs Financial Overview
Table Bayer Anthelmintic Drugs Financial Overview
Table Sun Pharmaceutical Industries Anthelmintic Drugs Financial Overview
Table Johnson & Johnson Anthelmintic Drugs Financial Overview
Figure Global Anthelmintic Drugs Revenue (Millions USD) and Growth Rate (2019-2027)
Table Anthelmintic Drugs Market Forecast by Regions (2019-2027)
Figure North America Anthelmintic Drugs Market Forecast (2019-2027)
Figure United States Anthelmintic Drugs Market Forecast (2019-2027)
Figure Canada Anthelmintic Drugs Market Forecast (2019-2027)
Figure Mexico Anthelmintic Drugs Market Forecast (2019-2027)
Figure Europe Anthelmintic Drugs Market Forecast (2019-2027)
Figure Germany Anthelmintic Drugs Market Forecast (2019-2027)
Figure France Anthelmintic Drugs Market Forecast (2019-2027)
Figure UK Anthelmintic Drugs Market Forecast (2019-2027)
Figure Russia Anthelmintic Drugs Market Forecast (2019-2027)
Figure Italy Anthelmintic Drugs Market Forecast (2019-2027)
Figure Rest of Europe Anthelmintic Drugs Market Forecast (2019-2027)
Figure Asia-Pacific Anthelmintic Drugs Market Forecast (2019-2027)
Figure China Anthelmintic Drugs Market Forecast (2019-2027)
Figure Japan Anthelmintic Drugs Market Forecast (2019-2027)
Figure Korea Anthelmintic Drugs Market Forecast (2019-2027)
Figure India Anthelmintic Drugs Market Forecast (2019-2027)
Figure Southeast Asia Anthelmintic Drugs Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Anthelmintic Drugs Market Forecast (2019-2027)
Figure South America Anthelmintic Drugs Market Forecast (2019-2027)
Figure Brazil Anthelmintic Drugs Market Forecast (2019-2027)
Figure Argentina Anthelmintic Drugs Market Forecast (2019-2027)
Figure Columbia Anthelmintic Drugs Market Forecast (2019-2027)
Figure Rest of South America Anthelmintic Drugs Market Forecast (2019-2027)
Figure Middle East and Africa Anthelmintic Drugs Market Forecast (2019-2027)
Figure Saudi Arabia Anthelmintic Drugs Market Forecast (2019-2027)
Figure United Arab Emirates Anthelmintic Drugs Market Forecast (2019-2027)
Figure Egypt Anthelmintic Drugs Market Forecast (2019-2027)
Figure Nigeria Anthelmintic Drugs Market Forecast (2019-2027)
Figure South Africa Anthelmintic Drugs Market Forecast (2019-2027)
Figure Turkey Anthelmintic Drugs Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Anthelmintic Drugs Market Forecast (2019-2027)
Figure Global Anthelmintic Drugs Forecast by Type (2019-2027)
Figure Global Anthelmintic Drugs Market Share Forecast by Type (2019-2027)
Figure Global Anthelmintic Drugs Forecast by Type (2019-2027)
Figure Global Anthelmintic Drugs Forecast by Application (2019-2027)
Figure Global Anthelmintic Drugs Market Share Forecast by Application (2019-2027)
Figure Global Anthelmintic Drugs Forecast by Application (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|